Moderna (NASDAQ: MRNA) shareholders approved all four management proposals at the company's 2026 Annual Meeting, including the election of directors, executive compensation, and the appointment of Ernst & Young as auditor. The approvals signal shareholder confidence in the company's current leadership and strategy.
Moderna Shareholders Approve Management Proposals at AGM
AGMcorporate governanceshareholder votebiotechnology
